IPO
Bonus Biogroup Ltd.
Filed with the SEC to go public on May 9, 2025. Newest amendment Mar 31, 2026.
Terms
| Price range | US$4.00 to US$6.00 an ADS | |
| ADSs offered | 3,750,000 American depositary shares | |
| Offering size | US$15 million to US$22.5 million | ADSs offered times the price range, worked out by 6ix |
| Underwriters' option | Up to 562,500 more ADSs | |
| Listing | BONS on the Nasdaq Capital Market | Has applied to list |
| Underwriter | D. Boral Capital |
From the cover of the amended prospectus (F-1/A) filed Mar 31, 2026
Steps
| Draft sent to the SEC in confidence | Feb 27, 2025 |
| Filed publicly | May 9, 2025 |
| Amended 4 times | Newest Mar 31, 2026 |
| Shares registered with an exchange | Not yet |
| Declared effective by the SEC | Not yet |
| Final prospectus, with the price | Not yet |
Filings
- Mar 31, 2026 F-1/A · Registration statement, amended
- Mar 19, 2026 F-1/A · Registration statement, amended
- Mar 12, 2026 FWP · Free writing prospectus
- Mar 12, 2026 F-1/A · Registration statement, amended
- Nov 28, 2025 F-1/A · Registration statement, amended
- May 9, 2025 F-1 · Registration statement
- Apr 10, 2025 DRS/A · Draft registration statement, amended
- Feb 27, 2025 DRS · Draft registration statement